Bone Marrow Aspirate Concentration in Posterior Cervical Fusion (BMAC)
Sponsor: Harvest Technologies
Terminated
Sponsor closed study due to low enrollment~Sponsor closed study due to low enrollment~Sponsor closed study due to low enrollment.
Other terminated trials from Harvest Technologies
- Congestive Heart Failure · Phase PHASE1/PHASE2 · Dec 2013
- Congestive Heart Failure · Phase PHASE1/PHASE2 · Apr 2013
- Diabetes · Phase NA · Sep 2005
More terminations from Harvest Technologies
Listed as NCT02068547, this NA trial focuses on Cervical Myelopathy and Radiculopathy and remains terminated or withdrawn. Sponsored by Harvest Technologies, it has been updated 12 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Apr 2021 — Dec 2021 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Terminated NA
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Nov 2018 — Nov 2020 [monthly]
Terminated NA
-
Jun 2018 — Nov 2018 [monthly]
Terminated NA
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Dec 2017 — May 2018 [monthly]
Terminated NA
Status: Enrolling By Invitation → Terminated
-
Jan 2017 — Dec 2017 [monthly]
Enrolling By Invitation NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Harvest Technologies
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .